Institution view

Asclepius Technology Company Group (Suzhou) Co., Ltd.

Programs currently tracked for this institution in the public Translational Deal Radar dataset.

Car Nk

BiCAR-NK cells (ROBO1 CAR-NK cells)

BiCAR-NK cells (ROBO1 CAR-NK cells) is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at Asclepius Technology Company Group (Suzhou) Co., Ltd., with a possible patent signal linked through modality_match. Manual review is still required.

Phase1 · Unknown

View asset